S.2513

OTC Monograph Drug User Fee Transparency Act amends the Federal Food, Drug, and Cosmetic Act to enhance transparency and reporting on.

The OTC Monograph Drug User Fee Transparency Act amends the Federal Food, Drug, and Cosmetic Act to enhance transparency and reporting on over-the-counter drug monograph activities. It requires the Food and Drug Administration (FDA) to make publicly available, on its website, robust written minutes of all negotiation meetings between the FDA and the regulated industry, not later than 30 days after each meeting.